Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MIG--differential gene expression in mouse brain endothelial cells.

Paola Ghersa1, Maurizio Gelati, Jacques Colinge

  • 1Serono Pharmaceutical Research Institute, Geneva, Switzerland.

Neuroreport
|April 2, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing multiple facets of ligand-receptor network inference including single-cell proteomics.

Nucleic acids research·2026
Same author

Circulating DNA reveals nucleosome occupancy patterns that are associated with nucleosome-DNA affinity and are affected in cancer.

Genome medicine·2026
Same author

Perampanel as add-on in high-grade glioma-related epilepsy: Seizure control and QoL in a prospective, multicenter, real-world 6-month follow-up study.

Epilepsia open·2026
Same author

Integrated DNA and RNA profiling refines prognostic stratification independent of therapeutic actionability in cholangiocarcinoma.

BMC cancer·2026
Same author

In vitro evidence that perampanel modulates miR-21-5p and miR-29a-3p associated with anti-glioma effects.

Discover oncology·2026
Same author

Effectiveness and safety of endovascular therapy compared to intravenous thrombolysis in acute ischaemic stroke due to medium-vessel occlusions: a real-world multicentre study from the Italian SITS registry.

European stroke journal·2026

Interferon-gamma-induced monokine (MIG) is highly expressed in brain endothelial cells during CNS inflammation. Blocking MIG may reduce T lymphocyte attraction and benefit inflammatory CNS diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Central nervous system (CNS) diseases often involve blood-brain barrier (BBB) damage and immune cell infiltration.
  • Understanding endothelial cell regulation is crucial for inflammatory CNS diseases.

Purpose of the Study:

  • To identify genes involved in endothelial cell regulation during CNS inflammation.
  • To investigate the role of interferon-gamma (IFNgamma)-induced monokine (MIG) in CNS inflammation.

Main Methods:

  • Differential gene expression (DGE) analysis of mouse brain endothelial cells.
  • In vitro assessment of MIG's biological activity in attracting T lymphocytes.
  • Evaluation of anti-MIG antibodies for blocking MIG's mechanism.

Related Experiment Videos

Main Results:

  • MIG is highly expressed in brain endothelial cells under inflammatory conditions.
  • MIG produced by endothelial cells attracts T lymphocytes.
  • Anti-MIG antibodies can interfere with MIG-mediated T lymphocyte attraction.
  • The MIG receptor, CXCR3, is constitutively expressed on endothelial cells.

Conclusions:

  • MIG plays a significant role in T lymphocyte recruitment to the CNS during inflammation.
  • Blocking MIG presents a potential therapeutic strategy for CNS inflammatory diseases.
  • CXCR3 expression on endothelial cells may contribute to maintaining cytokine gradients in CNS inflammation.